Back to Search
ROBERT SMITH, MD
MD
Neurology Physician
NPI: 1477611960IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
H2008(TX)
CMS Specialties
PrimaryNEUROLOGY
Education
BAYLOR COLLEGE OF MEDICINE
Class of 1986
Clinical Trials (4)
4
Linked Trials
0
Recruiting
3
With Results
Varenicline Effects In Schizophrenic Smokers
NCT00548470COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia
NCT00231894COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors
NCT00802919COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
NCT00287820COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Nicotine receptor partial agonists for smoking cessation.
PMID 37142273·Cochrane Database Syst Rev·2023
1-meta
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.
PMID 26730716·PLoS One·2016
4-observational
Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study.
PMID 23200554·Schizophr Res·2013
2-rct
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
PMID 22475524·Psychiatry Res·2012
2-rct
Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study.
PMID 20457512·Schizophr Res·2010
2-rct
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month study.
PMID 19814947·J Clin Psychiatry·2009
4-observational
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
PMID 19251401·Schizophr Res·2009
3-trial
Ghrelin receptor (GHS-R1A) agonists show potential as interventive agents during aging.
PMID 18056963·Ann N Y Acad Sci·2007
6-review
Orthotopic retransplantation in heterotopic transplant recipients: 3 case reports.
PMID 16446229·J Heart Lung Transplant·2006
5-case
Developments in ghrelin biology and potential clinical relevance.
PMID 16213742·Trends Endocrinol Metab·2005
6-review
Molecular endocrinology and physiology of the aging central nervous system.
PMID 15561803·Endocr Rev·2005
6-review
Growth hormone secretagogues: prospects and potential pitfalls.
PMID 15261841·Best Pract Res Clin Endocrinol Metab·2004
6-review
Growth hormone secretagogue receptor family members and ligands.
PMID 11322507·Endocrine·2001
6-review
Immunosuppression and anti-inflammatory agents in ALS.
PMID 11466958·Amyotroph Lateral Scler Other Motor Neuron Disord·2000
6-review
Adenosine: A partial agonist of the growth hormone secretagogue receptor.
PMID 11027627·Biochem Biophys Res Commun·2000
7-preclinical
Ethanol consumption does not promote weight gain in female mice.
PMID 19136820·Ann Nutr Metab·2008
7-preclinical
The cost of event-based prospective memory: salient target events.
PMID 17576150·J Exp Psychol Learn Mem Cogn·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6560 FANNIN ST., SCURLOCK TOWER, 8TH FLOOR
HOUSTON, TX 77030 - Phone
- (713) 441-3780
Quick Facts
- NPI
- 1477611960
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile